Oxprenolol

CHEMBL546 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
265.4 g/mol
LogP
2.1
Phase
4

A non-selective beta-blocker with partial agonist activity used to treat high blood pressure, angina, and certain heart rhythm disorders. It lowers heart rate and blood pressure by blocking beta-adrenergic receptors in the heart and blood vessels.

Moleküler Ağırlık

265,3500 g/mol

LogP

2,10

TPSA

50,70 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=CCOc1ccccc1OCC(O)CNC(C)C

InChI

InChI=1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3

Molecular Formula

C15H23NO3

HBD / HBA

2 / 4

Döndürülebilir Bağlar

9

Ağır Atomlar

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A non-selective beta-blocker with partial agonist activity used to treat high blood pressure, angina, and certain heart rhythm disorders. It lowers heart rate and blood pressure by blocking beta-adrenergic receptors in the heart and blood vessels.

Yes, Oxprenolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL546. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4631. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.